↓ Skip to main content

American Association for Cancer Research

Risk Estimation for Healthy Women from Breast Cancer Families

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, January 2004
Altmetric Badge

Mentioned by

patent
4 patents

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
34 Mendeley
Title
Risk Estimation for Healthy Women from Breast Cancer Families
Published in
Cancer Epidemiology, Biomarkers & Prevention, January 2004
DOI 10.1158/1055-9965.epi-03-0090
Pubmed ID
Authors

Christi J van Asperen, M A Jonker, C E Jacobi, J E M van Diemen-Homan, E Bakker, M H Breuning, J C van Houwelingen, G H de Bock

Abstract

Risk estimation in breast cancer families is often estimated by use of the Claus tables. We analyzed the family histories of 196 counselees; compared the Claus tables with the Claus, the BRCA1/2, the BRCA1/2/ models; and performed linear regression analysis to extend the Claus tables with characteristics of hereditary breast cancer. Finally, we compared the Claus extended method with the Claus, the BRCA1/2, and the BRCA1/2/u models. We found 47% agreement for Claus table versus Claus model; 39% agreement for Claus table versus BRCA1/2 model; 48% agreement for Claus table versus BRCA1/2/u model; 37% agreement for Claus extended method versus Claus model; 44% agreement for Claus extended model versus BRCA1/2 model; and 66% agreement for Claus extended method versus BRCA1/2/u model. The regression formula (Claus extended method) for the lifetime risk for breast cancer was 0.08 + 0.40 (*) Claus Table + 0.07 (*) ovarian cancer + 0.08 (*) bilateral breast cancer + 0.07 (*) multiple cases. This new method for risk estimation, which is an extension of the Claus tables, incorporates information on the presence of ovarian cancer, bilateral breast cancer, and whether there are more than two affected relatives with breast cancer. This extension might offer a good alternative for breast cancer risk estimation in clinical practice.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 21%
Researcher 7 21%
Other 4 12%
Professor 3 9%
Student > Master 3 9%
Other 7 21%
Unknown 3 9%
Readers by discipline Count As %
Medicine and Dentistry 14 41%
Biochemistry, Genetics and Molecular Biology 3 9%
Mathematics 2 6%
Chemistry 2 6%
Agricultural and Biological Sciences 2 6%
Other 8 24%
Unknown 3 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2021.
All research outputs
#8,534,976
of 25,374,647 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#2,147
of 4,847 outputs
Outputs of similar age
#37,905
of 147,474 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#18
of 38 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,847 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.4. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 147,474 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.